|
BUB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47989999996512E-06 |
| Normal-vs-Stage2 |
1.437740E-02 |
| Normal-vs-Stage3 |
3.79139999999722E-05 |
| Normal-vs-Stage4 |
5.876300E-03 |
| Stage1-vs-Stage2 |
2.262800E-01 |
| Stage1-vs-Stage3 |
8.403600E-04 |
| Stage1-vs-Stage4 |
2.019500E-02 |
| Stage2-vs-Stage3 |
1.936180E-02 |
| Stage2-vs-Stage4 |
2.297900E-02 |
| Stage3-vs-Stage4 |
7.368800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.84072765310839E-12 |
| Normal-vs-AfricanAmerican |
3.71860000000224E-05 |
| Normal-vs-Asian |
6.868200E-02 |
| Caucasian-vs-AfricanAmerican |
4.743800E-01 |
| Caucasian-vs-Asian |
5.045600E-02 |
| AfricanAmerican-vs-Asian |
1.845990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22346577313692E-13 |
| Normal-vs-Female |
4.48270000008577E-07 |
| Male-vs-Female |
7.584200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.360800E-04 |
| Normal-vs-Extreme_Weight |
7.56380003075208E-09 |
| Normal-vs-Obese |
3.2618999999956E-06 |
| Normal-vs-Extreme_Obese |
1.727750E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.491900E-02 |
| Normal_Weight-vs-Obese |
5.491600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.621500E-03 |
| Extreme_Weight-vs-Obese |
6.558700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.006290E-02 |
| Obese-vs-Extreme_Obese |
2.012000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.778440E-03 |
| Normal-vs-Age(41-60Yrs) |
6.02110028502523E-10 |
| Normal-vs-Age(61-80Yrs) |
4.70819999986993E-07 |
| Normal-vs-Age(81-100Yrs) |
5.697900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.682200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.291970E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.955900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.822990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.818500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.682600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.58330024038855E-11 |
| Normal-VS-Type2 PRCC |
8.16890000088222E-08 |
| Normal-VS-KIRP CIMP |
2.376500E-04 |
| Normal-VS-Unclassified PRCC |
2.08159999999236E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.818100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.381200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.154350E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.380570E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.308800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.117820E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.42780000000642E-05 |
| Normal-vs-N1 |
2.77039999996287E-06 |
| Normal-vs-N2 |
1.149050E-01 |
| N0-vs-N1 |
3.622900E-04 |
| N0-vs-N2 |
3.702400E-02 |
| N1-vs-N2 |
5.953000E-01 |
|
|
